Drugs & Targets Guardant Health launches real-world clinical-genomic platform to accelerate precision oncology drug development July 02, 2020Vol.46 No.27
In Brief Frederic Pla named COO of The Parker Institute for Cancer Immunotherapy April 10, 2020Vol.46 No.15
In Brief Van Crocker Jr. named president and co-founder of CTCA Oncology Data, Analytics & Research Business April 10, 2020Vol.46 No.15
Drugs & Targets FDA approves Sarclisa in patients with previously treated MM March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants RMAT designation for CD30 CAR-T cell therapy in Hodgkin lymphoma indication March 06, 2020Vol.46 No.10
Drugs & Targets FDA grants tipifarnib Fast Track designation in T-cell lymphomas March 06, 2020Vol.46 No.10
